Addex Therapeutics Ltd (ADXN)
9.15
0.00 (0.00%)
USD |
NASDAQ |
May 07, 16:00
9.15
0.00 (0.00%)
After-Hours: 19:14
Addex Therapeutics Price to Book Value: 7.171 for May 7, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 7.171 |
| May 03, 2024 | 7.014 |
| May 02, 2024 | 6.936 |
| May 01, 2024 | 6.356 |
| April 30, 2024 | 5.996 |
| April 29, 2024 | 5.909 |
| April 26, 2024 | 12.62 |
| April 25, 2024 | 12.08 |
| April 24, 2024 | 12.19 |
| April 23, 2024 | 14.69 |
| April 22, 2024 | 15.11 |
| April 19, 2024 | 15.71 |
| April 18, 2024 | 16.43 |
| April 17, 2024 | 17.24 |
| April 16, 2024 | 17.71 |
| April 15, 2024 | 19.40 |
| April 12, 2024 | 20.04 |
| April 11, 2024 | 20.49 |
| April 10, 2024 | 21.35 |
| April 09, 2024 | 21.87 |
| April 08, 2024 | 17.12 |
| April 05, 2024 | 14.01 |
| April 04, 2024 | 12.84 |
| April 03, 2024 | 12.07 |
| April 02, 2024 | 10.38 |
| Date | Value |
|---|---|
| April 01, 2024 | 10.19 |
| March 28, 2024 | 10.03 |
| March 27, 2024 | 9.679 |
| March 26, 2024 | 9.444 |
| March 25, 2024 | 9.244 |
| March 22, 2024 | 9.185 |
| March 21, 2024 | 9.483 |
| March 20, 2024 | 9.562 |
| March 19, 2024 | 9.432 |
| March 18, 2024 | 9.389 |
| March 15, 2024 | 9.177 |
| March 14, 2024 | 8.786 |
| March 13, 2024 | 8.660 |
| March 12, 2024 | 9.170 |
| March 11, 2024 | 9.217 |
| March 08, 2024 | 9.013 |
| March 07, 2024 | 7.398 |
| March 06, 2024 | 7.124 |
| March 05, 2024 | 7.344 |
| March 04, 2024 | 7.829 |
| March 01, 2024 | 7.093 |
| February 29, 2024 | 7.453 |
| February 28, 2024 | 7.925 |
| February 27, 2024 | 7.987 |
| February 26, 2024 | 7.684 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4725
Minimum
Jun 28 2022
21.87
Maximum
Apr 09 2024
2.820
Average
2.330
Median
Jan 04 2022
Price to Book Value Benchmarks
| AC Immune SA | 1.231 |
| CRISPR Therapeutics AG | 2.504 |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | 0.5553 |
| MoonLake Immunotherapeutics | 5.550 |
Price to Book Value Related Metrics
| PS Ratio | 3.169 |
| Price | 9.15 |
| Earnings Yield | -204.0% |
| Market Cap | 9.780M |